Skip to content
Screener

Goodwill at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$21.74B-0.2%
Myriad Genetics logo
Myriad GeneticsMYGN
$47.1M-83.5%
Labcorp Holdings logo
Labcorp HoldingsLH
$7.03B+7.3%
Quest Diagnostics logo
Quest DiagnosticsDGX
$9.11B+2.6%
NeoGenomics logo
NeoGenomicsNEO
$524M0.0%
Natera, Inc. logo
Natera, Inc.NTRA
$141.1M

Segments

By segment

See full
Laboratory Services$31.38M
Therapeutic Development$22.35M+1.1%

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$526.64M-16.5%
Enterprise value$511.45M-6.7%
P/S1.6×-0.4×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 7:08 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-199065
Line itemMarch 31, 2026December 31, 2025
Fixed assets, net116,344112,549
In-process research & development68,49068,490
Other intangible assets, net85,49964,791
Goodwill53,73125,080
Other long-term assets24,97622,856
Total assets$1,156,369$1,213,525
Liabilities and Stockholders’ Equity
Current liabilities

Item 1. Financial Statements.

FAQ

What is Fulgent Genetics, Inc.'s goodwill?
Fulgent Genetics, Inc. (FLGT) reported goodwill of $53.73M in Q1 2026.
How has Fulgent Genetics, Inc.'s goodwill changed year-over-year?
Fulgent Genetics, Inc.'s goodwill increased by 143.6% year-over-year, from $22.06M to $53.73M.
What is the long-term trend for Fulgent Genetics, Inc.'s goodwill?
Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s goodwill has grown at a -16.2% compound annual growth rate (CAGR), from $50.9M to $25.08M.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.

Ask your AI about Fulgent Genetics, Inc.'s goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude